Update: Magnesium und Diabetes 2014

Zusammenfassung

Magnesium erfüllt im Körper zahlreiche Funktionen und hat u. a. protektive Bedeutung für das kardiovaskuläre System. Neuere Studien zeigen, dass Magnesium das Diabetesrisiko senken und den Krankheitsverlauf bei manifestem Diabetes Typ 2 positiv beeinflussen kann. Da der Magnesiumstatus von Diabetikern häufig schlecht ist, sollte ein Defizit ausgeglichen werden.

Schlüsselwörter

Magnesium - Serumkonzentration - Herz-Kreislauf-Erkankungen - Diabetesrisiko - C-reaktives Protein (CRP) - diabetische Folgeerkrankungen

• Literatur

• 1 Almoznino-Sarafian D, Berman S, Mor A et al. Magnesium and C-reactive protein in heart failure: an anti-inflammatory effect of magnesium administration?. Eur J Nutr 2007; 46: 230-237
• 2 Barbagallo M, Dominguez LJ, Resnick LM. Magnesium metabolism in hypertension and type 2 diabetes mellitus. Am J Ther 2007; 14: 375-385
• 3 Barbagallo M, Dominguez LJ, Galioto A et al. Oral magnesium supplementation improves vascular function in elderly diabetic patients. Magnes Res 2010; 23: 131-137
• 4 Chiuve SE, Korngold EC, Januzzi Jr JL et al. Plasma and dietary magnesium and risk of sudden cardiac death in women. Am J Clin Nutr 2011; 93: 253-260
• 5 Chiuve SE, Sun Q, Curhan GC et al. Dietary and plasma magnesium and risk of coronary heart disease among women. J Am Heart Assoc 2013; 2: e000114
• 6 de Baaij JHF, Hoenderop JGJ, Bindels RJM. Regulation of magnesium balance: lessons learned from human genetic disease. Clin Kidney J 2012; 5 (Suppl. 01) i15-i24
• 7 De Leeuw I, Engelen W, De Block C, Van Gall L. Long term magnesium supplementation influences favourably the natural evolution of neuropathy in Mg-depleted type 1 diabetic patients (T1 dm). Mag Res 2004; 17: 109-114
• 8 Del Gobbo LC, Imamura F, Wu JH et al. Circulating and dietary magnesium and risk of cardiovascular disease: a systematic review and meta-analysis of prospective studies. Am J Clin Nutr 2013; 98: 160-173
• 9 Dong JY, Xun P, He K, Qin LQ. Magnesium intake and risk of type 2 diabetes: meta-analysis of prospective cohort studies. Diabetes Care 2011; 34: 2116-2122
• 10 Durlach J. Magnesium in clinical practice. London, Paris: John Libbey & Co.; 1988
• 11 Guerrero-Romero F, Rodríguez-Morán M. Hypomagnesemia, oxidative stress, inflammation, and metabolic syndrome. Diabetes Metab Res Rev 2006; 22: 471-476
• 12 Guerrero-Romero F, Rascón-Pacheco RA, Rodríguez-Morán M et al. Hypomagnesaemia and risk for metabolic glucose disorders: a 10-year follow-up study. Eur J Clin Invest 2008; 38: 389-396
• 13 Hruby A, Meigs JB, OʼDonnell CJ et al. Higher magnesium intake reduces risk of impaired glucose and insulin metabolism and progression from prediabetes to diabetes in middle-aged americans. Diabetes Care 2014; 37: 419-427
• 14 Huang JH, Lu YF, Cheng FC et al. Correlation of magnesium intake with metabolic parameters, depression and physical activity in elderly type 2 diabetes patients: a cross-sectional study. Nutr J 2012; 11: 41
• 15 Huerta MG, Roemmich JN, Kington ML et al. Magnesium deficiency is associated with insulin resistance in obese children. Diabetes Care 2005; 28: 1175-1181
• 16 Ismail Y, Ismail AA, Ismail AA. The underestimated problem of using serum magnesium measurements to exclude magnesium deficiency in adults; a health warning is needed for “normal” results. Clin Chem Lab Med 2010; 48: 323-327
• 17 Kim DJ, Xun P, Liu K et al. Magnesium intake in relation to systemic inflammation, insulin resistance, and the incidence of diabetes. Diabetes Care 2010; 33: 2604-2610
• 18 Larsson SC, Wolk A. Magnesium intake and risk of type 2 diabetes: a meta-analysis. J Intern Med 2007; 262: 208-214
• 19 Liao F, Folsom AR, Brancati FL. Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 1998; 136: 480-490
• 20 Ma J, Folsom AR, Melnick SL et al. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC study. Atherosclerosis Risk in Communities Study. J Clin Epidemiol 1995; 48: 927-940
• 21 Nielsen FH, Johnson LK, Zeng H. Magnesium supplementation improves indicators of low magnesium status and inflammatory stress in adults older than 51 years with poor quality sleep. Magnes Res 2010; 23: 158-168
• 22 Peacock JM, Ohira T, Post W et al. Serum magnesium and risk of sudden cardiac death in the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 2010; 160: 464-470
• 23 Peters KE, Chubb SA, Davis WA, Davis TM. The relationship between hypomagnesemia, metformin therapy and cardiovascular disease complicating type 2 diabetes: the Fremantle Diabetes Study. PLoS One 2013; 8: e74355
• 24 Pham PC, Pham PM, Pham PT et al. The link between lower serum magnesium and kidney function in patients with diabetes mellitus type 2 deserves a closer look. Clin Nephrol 2009; 71: 375-379
• 25 Qu X, Jin F, Hao Y et al. Magnesium and the risk of cardiovascular events: a meta-analysis of prospective cohort studies. PLoS One 2013; 8: e57720
• 26 Rude RK. Magnesium deficiency: a cause of heterogeneous disease in humans. Bone Miner Res 1998; 13: 749-758
• 27 Rylander R, Remer T, Berkemeyer S, Vormann J. Acid-base status affects renal magnesium losses in healthy, elderly persons. J Nutr 2006; 136: 2374-2377
• 28 Shechter M. Does magnesium have a role in the treatment of patients with coronary artery disease?. Am J Cardiovasc Drugs 2003; 3: 231-239
• 29 Song Y, He K, Levitan EB et al. Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: a meta-analysis of randomized double-blind controlled trials. Diabet Med 2006; 23: 1050-1056
• 30 Song Y, Li TY, van Dam RM et al. Magnesium intake and plasma concentrations of markers of systemic inflammation and endothelial dysfunction in women. Am J Clin Nutr 2007; 85: 1068-1074
• 31 Touyz RM. Transient receptor potential melastatin 6 and 7 channels, magnesium transport, and vascular biology: implications in hypertension. Am J Physiol Heart Circ Physiol 2008; 294: H1103-1118
• 32 Von Ehrlich B, Wadepuhl M. Erhöhtes Risiko einer diabetischen Retinopathie bei niedrigem Serum-Magnesium. Diabetes und Stoffwechsel 2003; 12: 285-289
• 33 Vormann J. Magnesium. In: Stipanuk MH, Caudill MA, Hrsg. Biochemical, Physiological, and Molecular Aspects of Human Nutrition. 3. Aufl. Elsevier; 2012: 747-758
• 34 Walker AF, Marakis G, Christie S, Byng M. Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study. Magnes Res 2003; 16: 183-191
• 35 Wang J, Persuitte G, Olendzki BC et al. Dietary magnesium intake improves insulin resistance among non-diabetic individuals with metabolic syndrome participating in a dietary trial. Nutrients 2013; 5: 3910-3919
• 36 Weisinger JR, Bellorin-Font E. Magnesium and phosphorus. Lancet 1998; 352: 391-396